Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma, Kaposi 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hematologic Diseases 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1

Interventions

Gemcitabine 39 Cisplatin 24 Oxaliplatin 15 pembrolizumab 12 Capecitabine 12 Fluorouracil 9 Leucovorin 7 Albumin-Bound Paclitaxel 7 lenvatinib 6 Radiofrequency Ablation 6 Panitumumab 6 130-nm albumin-bound paclitaxel 6 Irinotecan 5 Bevacizumab 5 durvalumab 4 Taxes 4 Nivolumab 4 Hepatectomy 4 Drug Therapy 4 tremelimumab 3 apatinib 3 Radiosurgery 3 Platinum 3 Injections 3 Floxuridine 3 Cetuximab 3 1,2-diaminocyclohexaneplatinum II citrate 3 trametinib 2 spartalizumab 2 sintilimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Cholangiocarcinoma × Association × Clear all

NCT01912053 2018-05-11

MispheC

Center Eugene Marquis

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡